Our research indicated that SLC12A8 upregulation could notably promote the EMT process in bladder cancer, suggesting that SLC12A8 might promote the malignant development of tumor by regulating the EMT process. This evidence concerns the gene SLC12A8 and urinary bladder carcinoma.